yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q30313340-DF96FA76-BD46-4C9D-91BD-A7FB32FB7C3E
Q30313340-DF96FA76-BD46-4C9D-91BD-A7FB32FB7C3E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30313340-DF96FA76-BD46-4C9D-91BD-A7FB32FB7C3E
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.
P2860
Q30313340-DF96FA76-BD46-4C9D-91BD-A7FB32FB7C3E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30313340-DF96FA76-BD46-4C9D-91BD-A7FB32FB7C3E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41d0bac52191a4eb866603981523f9525ac815d8
P2860
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.